Advanced search - COVID-19 Research Repository - COVID-19 - Our areas of work - Public Health Scotland

Filter by publication date

From

Month Year

Test

To

Month Year

Test

Apply date filter

Showing 10 results

Neoechinulin A as a promising SARS-CoV-2 Mpro inhibitor: in vitro and in silico study showing the ability of simulations in discerning active from inactive enzyme inhibitors

Author

Alhadrami, Hani A.; Burgio, Gaia; Thissera, Bathini; Orfali, Raha; Jiffri, Suzan E.; Yaseen, Mohammed; Sayed, Ahmed M.; Rateb, Mostafa E.

Source

Marine Drugs

Type

Journal article

Published

24 February 2022
Efficacy of ceftazidime and cefepime in the management of COVID-19 patients: single center report from Egypt

Author

Eid, Ragaey A.; Elgendy, Marwa O.; El-Gendy, Ahmed O.; Elgendy, Sara O.; Belbahri, Lassaad; Sayed, Ahmed M.; Rateb, Mostafa E.

Source

Antibiotics

Type

Journal article

Published

20 October 2021
Bioguided isolation of cyclopenin analogues as potential SARS-COV-2 Mpro inhibitors from Penicillium citrinum TDPEF34

Author

Thissera, Bathini; Sayed, Ahmed M.; Hassan, Marwa H.A.; Abdelwahab, Sayed F.; Amaeze, Ngozi; Semler, Valeria T.; Alenezi, Faizah N.; Yaseen, Mohammed; Alhadrami, Hani A.; Belbahri, Lassaad and 1 other

Source

Biomolecules

Type

Journal article

Published

15 September 2021
Marine sulfated polysaccharides as promising antiviral agents: a comprehensive report and modeling study focusing on SARS CoV-2

Author

Salih, Abdalla E. M.; Thissera, Bathini; Yaseen, Mohammed; Hassane, Ahmed S. I.; El-Seedi, Hesham R.; Sayed, Ahmed M.; Rateb, Mostafa E.

Source

Marine Drugs

Type

Journal article

Published

22 July 2021
Scaffold hopping of α-rubromycin enables direct access to FDA-approved cromoglicic acid as a SARS-CoV-2 MPro inhibitor

Author

Alhadrami, Hani A.; Sayed, Ahmed M.; Al-Khatabi, Heba; Alhakamy, Nabil A.; Rateb, Mostafa E.

Source

Pharmaceuticals

Type

Journal article

Published

05 June 2021
Cnicin as an anti-SARS-CoV-2: an integrated in silico and in vitro approach for the rapid identification of potential COVID-19 therapeutics

Author

Alhadrami, Hani A.; Sayed, Ahmed M.; Hassan, Hossam M.; Youssif, Khayrya A.; Gaber, Yasser; Moatasim, Yassmin; Kutkat, Omnia; Mostafa, Ahmed; Ali, Mohamed Ahmed; Rateb, Mostafa E. and 2 others

Source

Antibiotics

Type

Journal article

Published

07 May 2021
Olive-derived triterpenes suppress SARS COV-2 main protease: a promising scaffold for future therapeutics

Author

Alhadrami, Hani A.; Sayed, Ahmed M.; Sharif, Ahmed M.; Azhar, Esam I.; Rateb, Mostafa E.

Source

Molecules

Type

Journal article

Published

01 May 2021
Cyanobacteria-from the oceans to the potential biotechnological and biomedical applications

Author

Khalifa, Shaden A. M.; Shedid, Eslam S.; Saied, Essa M.; Jassbi, Amir Reza; Jamebozorgi, Fatemeh H.; Rateb, Mostafa E.; Du, Ming; Abdel-Daim, Mohamed M.; Kai, Guo-Yin; Al-Hammady, Montaser A. M. and 3 others

Source

Marine Drugs

Type

Journal article

Published

24 April 2021
Microbial natural products as potential inhibitors of SARS-CoV-2 main protease (Mpro)

Author

Sayed, Ahmed M.; Alhadrami, Hani A.; El-Gendy, Ahmed O.; Shamikh, Yara I.; Belbahri, Lassaad; Hassan, Hossam M.; Abdelmohsen, Usama Ramadan; Rateb, Mostafa E.

Source

Microorganisms

Type

Journal article

Published

29 July 2020
Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale

Author

Sayed, Ahmed M.; Khattab, Amira R.; AboulMagd, Asmaa M.; Hassan, Hossam M.; Rateb, Mostafa E.; Zaid, Hala; Abdelmohsen, Usama Ramadan

Source

RSC Advances

Type

Journal article

Published

27 May 2020

There are no more search results.